Panel Discussion: Practical Approaches for Creating a Compelling Preclinical Data Package for IND Submission to Move ASIT Therapies from the Lab to the Clinic
Time: 1:00 pm
day: Custom Day Two
Details:
• Highlighting the importance of robust clinical data to secure funding, partnerships, and regulatory buy-in in a new area with limited proof-of-concept studies
• Turbocharging the development of humanized mouse models and organoids to accurately replicate human autoimmune diseases for increased preclinical data
• Evaluating strategies for first in-human trials: when and where should the first patient be dosed?
